
Miranix Tablet ER
Marketer
Ajanta Pharma Ltd
Salt Composition
Mirabegron (25mg)
Overview Miranix Tablet ER
Extended-release Miranix tablets alleviate overactive bladder symptoms such as heightened urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your physician's prescribed dosage and duration. Miranix ER tablets may be taken with or without food; swallow them whole, avoiding crushing or chewing. Discontinue use only after consulting your doctor, as abrupt cessation may exacerbate symptoms. Complete the prescribed course for optimal therapeutic benefit. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your doctor promptly. Prior to treatment, disclose all other medications and pre-existing conditions. Inform your doctor about pregnancy or breastfeeding. Individuals with hepatic or renal impairment require close monitoring and regular follow-up appointments as directed by their physician.
Uses of Miranix Tablet ER
Managing symptoms associated with overactive bladder
Major Benefits of Miranix Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Miranix Extended-Release tablet whole; do not damage it by chewing, crushing, or breaking. While you can take it with or without food, consistency is key—take it at the same time each day.
Common Side effects of Miranix Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Miranix Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Miranix Tablet ER. Always swallow the tablet whole; avoid chewing, crushing, or breaking it. Miranix Tablet ER can be administered with or without food, although consistent timing is recommended.
How Miranix Tablet ER works:
Miranix Extended-Release tablets contain a beta-3 adrenergic agonist. This medication's action involves stimulating bladder beta-3 receptors, leading to detrusor muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Miranix Extended-Release Tablets with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Extended-release Miranix tablets might pose pregnancy risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Miranix tablets pose a likely risk during lactation. Available human data indicates potential transfer to breast milk, potentially harming the infant.
DrivingSAFE
Driving ability is typically unaffected by Miranix Extended-Release Tablets.
KidneyCAUTION
Exercise caution when prescribing Miranix Extended-Release tablets to individuals with advanced renal impairment. Dosage modification of Miranix Extended-Release may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Miranix Tablet ER cautiously, potentially requiring dosage modification. Consult a physician before use. Miranix Tablet ER is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Miranix Tablet ER :
Should you forget a Miranix Extended-Release tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Miranix Tablet ER
| Label | Value |
|---|---|
| Type of Compound | Amide-based compound |
| Addictive | None. |
| Medication Classification | The study of the urinary tract and male reproductive system. |
| Mechanism of Action | Beta-3 adrenergic receptor-selective stimulant (urinary bladder) |
